IPO Journey
Sonoma Pharmaceuticals, Inc.
IPO Date: April 27, 2026 · 3 filings tracked
Final Offer Terms
Ticker
SNOA
Exchange
Nasdaq Capital Market
Offer Price
$1.35
Shares Offered
2,962,962
Estimated Proceeds
$4.0M
Underwriters
Led by Dawson James Securities, Inc.
Filing Timeline
1
S-1
April 17, 2026
- Established technology platform based on hypochlorous acid (HOCl) since 1999
- Strong global footprint with products sold in over 55 countries
2
S-1/A
April 23, 2026
- Proprietary Microcyn® technology platform with 20+ years of development
- Proven market reach with 22 FDA clearances and distribution in 55+ countries
Changes from previous filing
- ▸ Final offer price: $2.47 per share
- ▸ Shares offered: 2,024,291
- ▸ Estimated proceeds: $4M
424B4
Final Pricing
April 27, 2026
- Patented Microcyn® technology mimics human immune response to fight infection
- FDA-cleared product portfolio spanning skin, oral, and wound care
Changes from previous filing
- ▸ Final offer price: $1.35 per share
- ▸ Shares offered: 2,962,962
- ▸ Estimated proceeds: $3M
Disclaimer: AI-generated analysis for informational purposes only. Not financial advice. Always conduct your own research.